Licona-Lasteros Karel Cesar, Navarrete-Medina Eduardo, Franco-Topete Karina, Rodriguez-Preciado Sergio Yair, Palomares-Marin Jaime, Cazarez-Navarro Gerardo, Franco-Topete Ramón Antonio, Hernández-Cañaveral Iván Isidro
Programa de Doctorado en Microbiología Médica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
Infect Dis Rep. 2025 Aug 14;17(4):100. doi: 10.3390/idr17040100.
BACKGROUND/OBJECTIVES: Epstein-Barr virus (EBV) detection patterns in lymphoproliferative disorders (LPDs) show significant geographical variation worldwide. Regional epidemiological data are essential for understanding viral distribution patterns and developing appropriate clinical surveillance strategies. This study aimed to determine EBV detection frequency in LPDs using available molecular and immunohistochemical methods in Western Mexico.
We conducted a cross-sectional study of 200 formalin-fixed paraffin-embedded tissue samples from patients diagnosed with LPDs (2015-2019) at Hospital Civil de Guadalajara. EBV detection combined with real-time PCR targeting the BNTp143 gene and immunohistochemistry for LMP-1 protein. Cases were classified following current WHO criteria. Statistical analysis included multivariate logistic regression, diagnostic concordance assessment, and age-stratified analysis.
EBV detection frequency reached 35.5% overall, with marked differences between neoplastic (53.9%) and reactive LPDs (24.2%) (OR: 3.515; 95% CI: 1.859-6.645, < 0.001). Hodgkin lymphoma showed the highest detection rate (80.6%), significantly exceeding non-Hodgkin lymphoma (39.3%) (OR: 6.43; 95% CI: 2.08-19.41, = 0.001). Age-stratified analysis revealed predominant adult involvement (49.1% vs. 22.0% in young adults, = 0.025). We identified three epidemiological categories based on detection probability patterns.
This study represents the first comprehensive molecular and immunohistochemical characterization of Epstein-Barr virus in lymphoproliferative disorders from Western Mexico, establishing distinct epidemiological patterns that align with Latin American regional characteristics. The validated methodology provides a reproducible framework for multi-center studies, while the epidemiological data serve as an essential baseline for future longitudinal research and resource optimization in similar healthcare settings.
背景/目的:在全球范围内,淋巴增生性疾病(LPD)中爱泼斯坦-巴尔病毒(EBV)的检测模式存在显著的地域差异。区域流行病学数据对于了解病毒分布模式和制定适当的临床监测策略至关重要。本研究旨在利用墨西哥西部现有的分子和免疫组化方法确定LPD中EBV的检测频率。
我们对瓜达拉哈拉市民医院2015年至2019年诊断为LPD的患者的200份福尔马林固定石蜡包埋组织样本进行了横断面研究。采用针对BNTp143基因的实时PCR和LMP-1蛋白免疫组化联合检测EBV。病例根据现行世界卫生组织标准进行分类。统计分析包括多因素逻辑回归、诊断一致性评估和年龄分层分析。
EBV总体检测频率达到35.5%,肿瘤性LPD(53.9%)和反应性LPD(24.2%)之间存在显著差异(比值比:3.515;95%置信区间:1.859 - 6.645,P < 0.001)。霍奇金淋巴瘤的检测率最高(80.6%),显著超过非霍奇金淋巴瘤(39.3%)(比值比:6.43;95%置信区间:2.08 - 19.41,P = 0.001)。年龄分层分析显示主要累及成年人(49.1%,而年轻人为22.0%,P = 0.025)。我们根据检测概率模式确定了三种流行病学类别。
本研究首次对墨西哥西部淋巴增生性疾病中的爱泼斯坦-巴尔病毒进行了全面的分子和免疫组化特征分析,建立了与拉丁美洲区域特征相符的独特流行病学模式。经过验证的方法为多中心研究提供了可重复的框架,而流行病学数据则为未来类似医疗环境中的纵向研究和资源优化提供了重要的基线。